Biotech

All Articles

Oncternal equity sinks 60% among cutbacks, test firings

.Cancer company Oncternal Therapies is folding all its professional trials as well as giving up work...

Roche is holding out hopes that its own injectable obesity possibility can at some point show 25% weight-loss in late-stage test

.Roche is storing out hopes that its injectable excessive weight possibility might eventually demons...

Novo Nordisk hails 'exceptional' weight reduction result for dual-acting dental drug in very early trial

.Novo Nordisk has actually raised the lid on a stage 1 trial of its dental amylin as well as GLP-1 r...

AbbVie takes legal action against BeiGene over blood cancer cells drug proprietary knowledge

.Only a handful of quick weeks after winning an FDA Fast Track tag for its own investigational BTK d...

Lilly supplies one-two blow along with second tranche of favorable data on weekly the hormone insulin candidate

.Quickly after a good data decrease for Eli Lilly's efsitora alfa, the Indianapolis-based business i...

BridgeBio cuts gene therapy finances as professional records disappoint

.BridgeBio Pharma is actually slashing its own gene treatment finances and also pulling back coming ...

GSK gives up HSV injection wishes after phase 2 neglect, yielding race to Moderna, BioNTech

.GSK's effort to build the initial vaccine for genital herpes simplex virus (HSV) has ended in failu...

GSK's long-acting bronchial asthma drug cut in half strikes in phase 3

.GSK's long-acting breathing problem therapy has actually been actually shown to halve the variety o...

AstraZeneca, Daiichi unpack Dato-DXd's general survival fall short

.AstraZeneca as well as Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has stopped wo...

Roivant reveals brand-new 'vant' to advance Bayer high blood pressure med

.Matt Gline is back with a brand new 'vant' company, after the Roivant Sciences CEO spent Bayer $14 ...